Monday, 19 September 2022

Sandoz releases postive trial result of denosumab

Sandoz releases postive trial result of denosumab
Sandoz releases postive trial result of denosumab

Sandoz announces the release of positive results from the integrated ROSALIA Phase 3 clinical trial study for its proposed biosimilar denosumab.

Rajesh Vagh Mon, 09/19/2022 - 13:37

source https://www.pharmatutor.org/pharma-news/2022/sandoz-releases-postive-trial-result-of-denosumab

No comments:

Post a Comment

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...